Literature DB >> 11888528

Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity.

Robert S Rosenson1, Susan Shott, Christine C Tangney.   

Abstract

Elevated blood viscosity is a predictor of cardiovascular disease. The major determinants of blood viscosity are hematocrit and plasma viscosity. Plasma triglycerides elevate plasma viscosity; however, the contribution of plasma triglycerides to blood viscosity after adjustment for other major covariates has not been reported. This cross-sectional study of 257 adult subjects evaluated the associations between fasting plasma lipids, fibrinogen, total serum protein, hematocrit and blood viscosity. Blood viscosity was measured at 37 degrees C with a coaxial cylinder microviscometer at shear rates of 100 and 1 s(-1). Blood viscosity values are reported both as uncorrected measurements and measurements corrected to a hematocrit of 45% by a regression equation. Uncorrected blood viscosity at a shear rate of 100 s(-1) was significantly associated with triglycerides, fibrinogen, high density lipoprotein (HDL) cholesterol, total serum protein, and hematocrit using stepwise multivariate regression analysis. When corrected blood viscosity at 100 s(-1) was the dependent variable, there were statistically significant associations with triglycerides, HDL cholesterol, and total serum protein. Corrected blood viscosity at 1 s(-1) was significantly associated with triglycerides, fibrinogen, total serum protein, and an indicator variable for diabetes mellitus. This study supports an additional mechanism whereby triglycerides may contribute to cardiovascular risk.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11888528     DOI: 10.1016/s0021-9150(01)00656-6

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  20 in total

1.  Detrimental effect of systemic vascular risk factors on brain hemodynamic function assessed with MRI.

Authors:  Kevin S King; Min Sheng; Peiying Liu; Christopher D Maroules; Craig D Rubin; Ron M Peshock; Roderick W McColl; Hanzhang Lu
Journal:  Neuroradiol J       Date:  2018-01-10

2.  Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia.

Authors:  Signe Sloth Mogensen; Kjeld Schmiegelow; Kathrine Grell; Birgitte Klug Albertsen; Peder Skov Wehner; Peter Kampmann; Thomas Leth Frandsen
Journal:  Haematologica       Date:  2017-02-16       Impact factor: 9.941

Review 3.  Endothelial shear stress and blood viscosity in peripheral arterial disease.

Authors:  Young I Cho; Daniel J Cho; Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2014-04       Impact factor: 5.113

4.  Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe?

Authors:  Harsha Prasada Lashkari; Donna Lancaster; Ayad Atra; Michael P Champion; Mary M Taj
Journal:  Int J Hematol       Date:  2011-11-08       Impact factor: 2.490

Review 5.  Hypertriglyceridemia-why, when and how should it be treated?

Authors:  I Gouni-Berthold; W Krone
Journal:  Z Kardiol       Date:  2005-11

6.  Plasmapheresis for hypertriglyceridemia: The association between blood viscosity and triglyceride clearance rate.

Authors:  Hung-Chieh Wu; Lin-Chien Lee; Wei-Jie Wang
Journal:  J Clin Lab Anal       Date:  2018-10-15       Impact factor: 2.352

7.  The effects of experimental hypothyroidism on hemorheology and plasma fibrinogen concentration.

Authors:  Selmin Toplan; Nuran Dariyerli; Semra Ozdemir; Mehmet Can Akyolcu; Hüsrev Hatemi; Günnur Yigit
Journal:  Endocrine       Date:  2005-11       Impact factor: 3.633

8.  Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia.

Authors:  Deepa Bhojwani; Rashid Darbandi; Deqing Pei; Laura B Ramsey; Wassim Chemaitilly; John T Sandlund; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Sima Jeha; Monika L Metzger
Journal:  Eur J Cancer       Date:  2014-07-30       Impact factor: 9.162

9.  Low HDL levels and the risk of death, sepsis and malignancy.

Authors:  Renana Shor; Julio Wainstein; David Oz; Mona Boaz; Zipora Matas; Asora Fux; Aaron Halabe
Journal:  Clin Res Cardiol       Date:  2007-12-01       Impact factor: 5.460

10.  Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip.

Authors:  Tom R Gaunt; Delilah Zabaneh; Steve E Humphries; Ian N Day; Sonia Shah; Anna Guyatt; Christophe Ladroue; Meena Kumari; Fotios Drenos; Tina Shah; Philippa J Talmud; Juan Pablo Casas; Gordon Lowe; Ann Rumley; Debbie A Lawlor; Mika Kivimaki; John Whittaker; Aroon D Hingorani
Journal:  Thromb Haemost       Date:  2013-08-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.